Understanding Typhoid Disease After Vaccination: a Single Centre, Randomised, Doubleblind, Placebo Controlled Study to Evaluate M01ZH09 in a Healthy Adult Challenge Model, Using Ty21a Vaccine as a Positive Control.

Trial Profile

Understanding Typhoid Disease After Vaccination: a Single Centre, Randomised, Doubleblind, Placebo Controlled Study to Evaluate M01ZH09 in a Healthy Adult Challenge Model, Using Ty21a Vaccine as a Positive Control.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Apr 2017

At a glance

  • Drugs Typhoid vaccine (Primary) ; Typhoid-vaccine-Ty21a
  • Indications Typhoid
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
    • 06 Nov 2015 Planned primary completion date changed from 1 Sep 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.
    • 13 Dec 2013 Accrual to date is 144% according to United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top